U.S. biotech IPOs dying on the vine

Iria · Nov 3, 2008, 03:35 AM

While the market for initial public offerings has virtually shut down in all industries, with no deals in the United States in nearly three months, biotechnology companies desperate for capital will likely be waiting in line far longer than others when it does reopen.
_____________
Source: USA Today

Nov 3, 2008, 03:35 AM	#1
Iria DriverHeaven Extreme Member Join Date: Apr 2004 Posts: 7,275 Rep Power: 89	U.S. biotech IPOs dying on the vine While the market for initial public offerings has virtually shut down in all industries, with no deals in the United States in nearly three months, biotechnology companies desperate for capital will likely be waiting in line far longer than others when it does reopen. _____________ Source: USA Today